(R,R)-(–)-2,3-Bis(tert-butylmethylphosphino)quinoxaline
ALDRICH/676403 - ≥95%
Synonym: (R) QuinoxP®
CAS Number: 866081-62-1
Empirical Formula (Hill Notation): C18H28N2P2
Molecular Weight: 334.38
MDL Number: MFCD10565649
Linear Formula: C18H28N2P2
Product Type: Chemical
| assay | ≥95% |
| form | solid |
| functional group | phosphine |
| InChI | 1S/C18H28N2P2/c1-17(2,3)2 |
| InChI key | DRZBLHZZDMCPGX-VXKWHMMOSA |
| mp | 100-104 °C |
| Quality Level | 100  |
| SMILES string | CP(c1nc2ccccc2nc1P(C)C(C) |
| Application: | Air-Stable and Highly Efficient Chiral Ligands |
| Application: | Efficient ligand exhibiting high levels of enantiocontrol in synthetic transformations ranging from metal-catalyzed 1,4-addition of arylboronic acids to alkylative ring opening to asymmetric hydrogenation. |
| Features and Benefits: | Advantages of the QuinoxP* Ligands: • It is not oxidized nor epimerized at ambient conditions in air • Enantioselectivities are outstanding for various reaction paradigms • Hydrogenations proceed under mild reaction conditions • Low catalyst loadings yield high TONs |
| General description: | (R,R)-(-)-2,3-Bis(tert-butylmethylphosphino)qui |
| Legal Information: | QuinoxP is a registered trademark of Nippon Chemical Industry Co., Ltd. |
| Packaging: | 100 mg in clear glass bottle |
| Packaging: | 500 mg in amber glass bottle |
| Symbol |  GHS06 |
| Signal word | Danger |
| Hazard statements | H301 - H315 - H319 - H335 - H413 |
| Precautionary statements | P273 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% |
| mp | 100-104 °C |
| UNSPSC | 12352005 |